commit df4bbec30a36ad0ab0af6d3588a36df3686578ff
Author: davidlagorce <david.lagorce@inserm.fr>
Date:   Sun Oct 3 10:11:04 2021 +0200

    OCT 2021

diff --git a/Epidemiological data/Rare disease epidemiology/nl_product9_prev.xml b/Epidemiological data/Rare disease epidemiology/nl_product9_prev.xml
old mode 100755
new mode 100644
index ce4ab3e..e8e90e2
--- a/Epidemiological data/Rare disease epidemiology/nl_product9_prev.xml	
+++ b/Epidemiological data/Rare disease epidemiology/nl_product9_prev.xml	
@@ -1,5 +1,5 @@
 <?xml version="1.0" encoding="ISO-8859-1"?>
-<JDBOR date="2021-09-01 04:50:47" version="1.3.7 / 4.1.7 [2020-12-03] (orientdb version)" copyright="Orphanet (c) 2021" dbserver="jdbc:sybase:Tds:canard.orpha.net:2020">
+<JDBOR date="2021-10-01 04:51:24" version="1.3.7 / 4.1.7 [2020-12-03] (orientdb version)" copyright="Orphanet (c) 2021" dbserver="jdbc:sybase:Tds:canard.orpha.net:2020">
   <Availability> 
     <Licence>
       <FullName lang="en">Creative Commons Attribution 4.0 International</FullName>
@@ -7,7 +7,7 @@
       <LegalCode>https://creativecommons.org/licenses/by/4.0/legalcode</LegalCode>
     </Licence>
   </Availability>
-  <DisorderList count="6030">
+  <DisorderList count="6034">
     <Disorder id="17601">
       <OrphaCode>166024</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=166024</ExpertLink>
@@ -11716,7 +11716,7 @@
     <Disorder id="126">
       <OrphaCode>567</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=567</ExpertLink>
-      <Name lang="nl">22q11.2 deletiesyndroom</Name>
+      <Name lang="nl">22q11.2-deletiesyndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -17486,7 +17486,7 @@
     <Disorder id="17528">
       <OrphaCode>163703</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=163703</ExpertLink>
-      <Name lang="nl">Febriele infectiegerelateerde epilepsie-syndroom</Name>
+      <Name lang="nl">Febriele infectie-gerelateerde epilepsie-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -24360,28 +24360,9 @@
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="4">
-        <Prevalence id="882">
-          <Source>17028542[PMID]_[EXPERT]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23739">
-            <Name lang="nl">1-9 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.2</ValMoy>
-          <PrevalenceGeographic id="24369">
-            <Name lang="nl">France</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
+      <PrevalenceList count="2">
         <Prevalence id="883">
-          <Source>20301321[PMID]</Source>
+          <Source>PMID: 20301321</Source>
           <PrevalenceType id="23683">
             <Name lang="nl">Geboorteprevalentie</Name>
           </PrevalenceType>
@@ -24400,7 +24381,7 @@
           </PrevalenceValidationStatus>
         </Prevalence>
         <Prevalence id="884">
-          <Source>20301321[PMID]</Source>
+          <Source>PMID: 20301321</Source>
           <PrevalenceType id="23669">
             <Name lang="nl">Puntprevalentie</Name>
           </PrevalenceType>
@@ -24410,7 +24391,7 @@
           <PrevalenceClass id="23746">
             <Name lang="nl">1-9 / 100 000</Name>
           </PrevalenceClass>
-          <ValMoy>4.0</ValMoy>
+          <ValMoy>2.0</ValMoy>
           <PrevalenceGeographic id="24362">
             <Name lang="nl">Finland</Name>
           </PrevalenceGeographic>
@@ -24418,25 +24399,6 @@
             <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
-        <Prevalence id="885">
-          <Source>ORPHANET</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23739">
-            <Name lang="nl">1-9 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23795">
-            <Name lang="nl">Europa</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25965">
-            <Name lang="nl">Not yet validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
       </PrevalenceList>
     </Disorder>
     <Disorder id="297">
@@ -24519,28 +24481,9 @@
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="5">
-        <Prevalence id="889">
-          <Source>[EXPERT]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23746">
-            <Name lang="nl">1-9 / 100 000</Name>
-          </PrevalenceClass>
-          <ValMoy>1.9</ValMoy>
-          <PrevalenceGeographic id="23795">
-            <Name lang="nl">Europa</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
+      <PrevalenceList count="3">
         <Prevalence id="890">
-          <Source>EUROCAT European surveillance of congenital anomalies 2005-2012[REG]</Source>
+          <Source>PMID: 18074387</Source>
           <PrevalenceType id="23683">
             <Name lang="nl">Geboorteprevalentie</Name>
           </PrevalenceType>
@@ -24550,7 +24493,7 @@
           <PrevalenceClass id="23746">
             <Name lang="nl">1-9 / 100 000</Name>
           </PrevalenceClass>
-          <ValMoy>1.3</ValMoy>
+          <ValMoy>1.24</ValMoy>
           <PrevalenceGeographic id="23795">
             <Name lang="nl">Europa</Name>
           </PrevalenceGeographic>
@@ -24559,7 +24502,7 @@
           </PrevalenceValidationStatus>
         </Prevalence>
         <Prevalence id="891">
-          <Source>22925539[PMID]</Source>
+          <Source>PMID: 22925539</Source>
           <PrevalenceType id="23683">
             <Name lang="nl">Geboorteprevalentie</Name>
           </PrevalenceType>
@@ -24596,25 +24539,6 @@
             <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
-        <Prevalence id="893">
-          <Source>9608092[PMID]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="nl">Geboorteprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23739">
-            <Name lang="nl">1-9 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.97</ValMoy>
-          <PrevalenceGeographic id="25293">
-            <Name lang="nl">Spain</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
       </PrevalenceList>
     </Disorder>
     <Disorder id="301">
@@ -28794,7 +28718,7 @@
     <Disorder id="415">
       <OrphaCode>1059</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1059</ExpertLink>
-      <Name lang="nl">Blue-rubber-blebnevus</Name>
+      <Name lang="nl">'Blue rubber bleb'-naevus</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -29640,7 +29564,7 @@
     <Disorder id="17785">
       <OrphaCode>168615</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=168615</ExpertLink>
-      <Name lang="nl">Erfelijke persistentie van alfa-foetoproteïne</Name>
+      <Name lang="nl">Hereditaire persistentie van alfa-foetoproteïne</Name>
       <DisorderType id="21408">
         <Name lang="nl">Biologische anomalie</Name>
       </DisorderType>
@@ -29689,7 +29613,7 @@
     <Disorder id="17784">
       <OrphaCode>168612</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=168612</ExpertLink>
-      <Name lang="nl">Congenitale deficiëntie in alfa-foetoproteïne</Name>
+      <Name lang="nl">Congenitale deficiëntie van alfa-foetoproteïne</Name>
       <DisorderType id="21408">
         <Name lang="nl">Biologische anomalie</Name>
       </DisorderType>
@@ -32564,7 +32488,7 @@
     <Disorder id="461">
       <OrphaCode>147</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=147</ExpertLink>
-      <Name lang="nl">Carbamoylfosfaatsynthetase 1-deficiëntie</Name>
+      <Name lang="nl">Deficiëntie van carbamoylfosfaatsynthetase 1</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -44059,7 +43983,7 @@
     <Disorder id="18018">
       <OrphaCode>178345</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=178345</ExpertLink>
-      <Name lang="nl">Aromataseovermaatsyndroom</Name>
+      <Name lang="nl">Syndroom van overmaat aan aromatase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -44206,7 +44130,7 @@
     <Disorder id="673">
       <OrphaCode>3137</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3137</ExpertLink>
-      <Name lang="nl">Alfa-N-acetylgalactosaminidasedeficiëntie</Name>
+      <Name lang="nl">Deficiëntie van alfa-N-acetylgalactosaminidase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -47579,7 +47503,7 @@
     <Disorder id="18013">
       <OrphaCode>178320</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=178320</ExpertLink>
-      <Name lang="nl">Acuut longletsel</Name>
+      <Name lang="nl">Acuut letsel van long</Name>
       <DisorderType id="21429">
         <Name lang="nl">Particulaire klinische situatie binnen een ziekte of syndroom</Name>
       </DisorderType>
@@ -47717,7 +47641,7 @@
     <Disorder id="671">
       <OrphaCode>760</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=760</ExpertLink>
-      <Name lang="nl">Purinenucleosidefosforylasedeficiëntie</Name>
+      <Name lang="nl">Deficiëntie van purinenucleosidefosforylase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -47855,7 +47779,7 @@
     <Disorder id="18009">
       <OrphaCode>178303</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=178303</ExpertLink>
-      <Name lang="nl">8q22.1 microdeletiesyndroom</Name>
+      <Name lang="nl">8q22.1-microdeletiesyndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -49061,8 +48985,8 @@
       <PrevalenceList count="1">
         <Prevalence id="16495">
           <Source>ORPHANET</Source>
-          <PrevalenceType id="23683">
-            <Name lang="nl">Geboorteprevalentie</Name>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
           </PrevalenceType>
           <PrevalenceQualification id="23704">
             <Name lang="nl">Class only</Name>
@@ -49074,8 +48998,8 @@
           <PrevalenceGeographic id="23844">
             <Name lang="nl">Wereldwijd</Name>
           </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25965">
-            <Name lang="nl">Not yet validated</Name>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
       </PrevalenceList>
@@ -51217,7 +51141,7 @@
     <Disorder id="763">
       <OrphaCode>46</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=46</ExpertLink>
-      <Name lang="nl">Adenylosuccinaatlyasedeficiëntie</Name>
+      <Name lang="nl">Deficiëntie van adenylosuccinaatlyase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -54260,7 +54184,7 @@
     <Disorder id="17931">
       <OrphaCode>171706</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=171706</ExpertLink>
-      <Name lang="nl">Kleine gestalte - uitgestelde botleeftijd door schildklierhormoonmetabolismedeficiëntie</Name>
+      <Name lang="nl">Kleine gestalte - vertraagde botleeftijd door deficiëntie in schildklierhormoonmetabolisme</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -54961,23 +54885,23 @@
         <Name lang="nl">Subtype van aandoening</Name>
       </DisorderGroup>
       <PrevalenceList count="1">
-        <Prevalence id="8483">
-          <Source>ORPHANET</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
+        <Prevalence id="16528">
+          <Source>PMID: 24616761</Source>
+          <PrevalenceType id="23683">
+            <Name lang="nl">Geboorteprevalentie</Name>
           </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
           </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          <PrevalenceClass id="23746">
+            <Name lang="nl">1-9 / 100 000</Name>
           </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23795">
-            <Name lang="nl">Europa</Name>
+          <ValMoy>1.51</ValMoy>
+          <PrevalenceGeographic id="25475">
+            <Name lang="nl">United Kingdom</Name>
           </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25965">
-            <Name lang="nl">Not yet validated</Name>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
       </PrevalenceList>
@@ -55587,22 +55511,22 @@
       </DisorderGroup>
       <PrevalenceList count="1">
         <Prevalence id="8484">
-          <Source>ORPHANET</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
+          <Source>PMID: 24616761</Source>
+          <PrevalenceType id="23683">
+            <Name lang="nl">Geboorteprevalentie</Name>
           </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
           </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          <PrevalenceClass id="23739">
+            <Name lang="nl">1-9 / 1 000 000</Name>
           </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23795">
-            <Name lang="nl">Europa</Name>
+          <ValMoy>0.6</ValMoy>
+          <PrevalenceGeographic id="25475">
+            <Name lang="nl">United Kingdom</Name>
           </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25965">
-            <Name lang="nl">Not yet validated</Name>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
       </PrevalenceList>
@@ -59366,7 +59290,7 @@
     <Disorder id="825">
       <OrphaCode>1177</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1177</ExpertLink>
-      <Name lang="nl">Vroeg beginnende cerebellaire ataxie met behoud van peesreflexen</Name>
+      <Name lang="nl">Vroeg optredende cerebellaire ataxie met behoud van peesreflexen</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -61831,7 +61755,7 @@
     <Disorder id="18389">
       <OrphaCode>199285</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=199285</ExpertLink>
-      <Name lang="nl">Erfelijke hypercarotenemie en vitamine A-deficiëntie</Name>
+      <Name lang="nl">Hereditaire hypercarotenemie en vitamine A-deficiëntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -73605,46 +73529,8 @@
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="3">
-        <Prevalence id="2529">
-          <Source>[EXPERT]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="nl">Geboorteprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23739">
-            <Name lang="nl">1-9 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.33</ValMoy>
-          <PrevalenceGeographic id="23795">
-            <Name lang="nl">Europa</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="2530">
-          <Source>8482284[PMID]_ORPHANET</Source>
-          <PrevalenceType id="23683">
-            <Name lang="nl">Geboorteprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23732">
-            <Name lang="nl">1-5 / 10 000</Name>
-          </PrevalenceClass>
-          <ValMoy>19.0</ValMoy>
-          <PrevalenceGeographic id="25006">
-            <Name lang="nl">Norway</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25965">
-            <Name lang="nl">Not yet validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="2531">
+      <PrevalenceList count="1">
+        <Prevalence id="16539">
           <Source>ORPHANET</Source>
           <PrevalenceType id="23669">
             <Name lang="nl">Puntprevalentie</Name>
@@ -73652,15 +73538,15 @@
           <PrevalenceQualification id="23704">
             <Name lang="nl">Class only</Name>
           </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          <PrevalenceClass id="23774">
+            <Name lang="nl">Unknown</Name>
           </PrevalenceClass>
           <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23795">
-            <Name lang="nl">Europa</Name>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
           </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25965">
-            <Name lang="nl">Not yet validated</Name>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
       </PrevalenceList>
@@ -74445,9 +74331,9 @@
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="2">
+      <PrevalenceList count="1">
         <Prevalence id="2504">
-          <Source>23610123[PMID]</Source>
+          <Source>PMID: 23610123 &amp; ORPHANET</Source>
           <PrevalenceType id="23669">
             <Name lang="nl">Puntprevalentie</Name>
           </PrevalenceType>
@@ -74461,27 +74347,8 @@
           <PrevalenceGeographic id="23844">
             <Name lang="nl">Wereldwijd</Name>
           </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25965">
-            <Name lang="nl">Not yet validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="2505">
-          <Source>ORPHANET</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23732">
-            <Name lang="nl">1-5 / 10 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23795">
-            <Name lang="nl">Europa</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25965">
-            <Name lang="nl">Not yet validated</Name>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
       </PrevalenceList>
@@ -74691,7 +74558,7 @@
     <Disorder id="901">
       <OrphaCode>157</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=157</ExpertLink>
-      <Name lang="nl">Carnitinepalmitoyltransferase II-deficiëntie</Name>
+      <Name lang="nl">Deficiëntie van carnitinepalmitoyltransferase II</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -77362,28 +77229,9 @@
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="5">
-        <Prevalence id="2609">
-          <Source>Central Brain Tumor registry of the United States 2005[REG]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="nl">Geboorteprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23746">
-            <Name lang="nl">1-9 / 100 000</Name>
-          </PrevalenceClass>
-          <ValMoy>2.0</ValMoy>
-          <PrevalenceGeographic id="25482">
-            <Name lang="nl">United States</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="2610">
-          <Source>Central Brain Tumor registry of the United States 2010-2014[REG]_29117289[PMID]</Source>
+      <PrevalenceList count="3">
+        <Prevalence id="16530">
+          <Source>PMID: 25249493</Source>
           <PrevalenceType id="23676">
             <Name lang="nl">Jaarlijkse incidentie</Name>
           </PrevalenceType>
@@ -77393,26 +77241,26 @@
           <PrevalenceClass id="23746">
             <Name lang="nl">1-9 / 100 000</Name>
           </PrevalenceClass>
-          <ValMoy>8.14</ValMoy>
-          <PrevalenceGeographic id="25482">
-            <Name lang="nl">United States</Name>
+          <ValMoy>4.15</ValMoy>
+          <PrevalenceGeographic id="24418">
+            <Name lang="nl">Germany</Name>
           </PrevalenceGeographic>
           <PrevalenceValidationStatus id="25958">
             <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
-        <Prevalence id="2611">
-          <Source>RARECARE surveillance of rare cancers in Europe[REG]</Source>
-          <PrevalenceType id="23676">
-            <Name lang="nl">Jaarlijkse incidentie</Name>
+        <Prevalence id="16538">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
           </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
           </PrevalenceQualification>
-          <PrevalenceClass id="23739">
-            <Name lang="nl">1-9 / 1 000 000</Name>
+          <PrevalenceClass id="23774">
+            <Name lang="nl">Unknown</Name>
           </PrevalenceClass>
-          <ValMoy>0.15</ValMoy>
+          <ValMoy>0.0</ValMoy>
           <PrevalenceGeographic id="23795">
             <Name lang="nl">Europa</Name>
           </PrevalenceGeographic>
@@ -77420,10 +77268,10 @@
             <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
-        <Prevalence id="2612">
-          <Source>RARECARE surveillance of rare cancers in Europe[REG]</Source>
-          <PrevalenceType id="23690">
-            <Name lang="nl">Levensprevalentie</Name>
+        <Prevalence id="2610">
+          <Source>Central Brain Tumor registry of the United States 2010-2014[REG]_29117289[PMID]</Source>
+          <PrevalenceType id="23676">
+            <Name lang="nl">Jaarlijkse incidentie</Name>
           </PrevalenceType>
           <PrevalenceQualification id="23711">
             <Name lang="nl">Value and class</Name>
@@ -77431,33 +77279,14 @@
           <PrevalenceClass id="23746">
             <Name lang="nl">1-9 / 100 000</Name>
           </PrevalenceClass>
-          <ValMoy>1.75</ValMoy>
-          <PrevalenceGeographic id="23795">
-            <Name lang="nl">Europa</Name>
+          <ValMoy>8.14</ValMoy>
+          <PrevalenceGeographic id="25482">
+            <Name lang="nl">United States</Name>
           </PrevalenceGeographic>
           <PrevalenceValidationStatus id="25958">
             <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
-        <Prevalence id="2613">
-          <Source>ORPHANET</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23746">
-            <Name lang="nl">1-9 / 100 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23795">
-            <Name lang="nl">Europa</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25965">
-            <Name lang="nl">Not yet validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
       </PrevalenceList>
     </Disorder>
     <Disorder id="1031">
@@ -87471,7 +87300,7 @@
     <Disorder id="1533">
       <OrphaCode>1299</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1299</ExpertLink>
-      <Name lang="nl">Branchio-skeleto-genitaal syndroom</Name>
+      <Name lang="nl">Branchioskeletogenitaal syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -89369,7 +89198,7 @@
     <Disorder id="16715">
       <OrphaCode>137776</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=137776</ExpertLink>
-      <Name lang="nl">Letaal congenitaal contractuursyndroom type 2</Name>
+      <Name lang="nl">Letale congenitale contracturen-syndroom type 2</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -89599,7 +89428,7 @@
     <Disorder id="16716">
       <OrphaCode>137783</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=137783</ExpertLink>
-      <Name lang="nl">Letaal congenitaal contractuursyndroom type 3</Name>
+      <Name lang="nl">Letale congenitale contracturen-syndroom type 3</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -89699,7 +89528,7 @@
     <Disorder id="1461">
       <OrphaCode>1215</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1215</ExpertLink>
-      <Name lang="nl">Autosomaal dominante opticusatrofie-plus syndroom</Name>
+      <Name lang="nl">Autosomaal dominante opticusatrofie plus-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -90519,7 +90348,7 @@
     <Disorder id="16744">
       <OrphaCode>137914</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=137914</ExpertLink>
-      <Name lang="nl">Choane atresie</Name>
+      <Name lang="nl">Choanale atresie</Name>
       <DisorderType id="21415">
         <Name lang="nl">Morfologische anomalie</Name>
       </DisorderType>
@@ -92641,7 +92470,7 @@
     <Disorder id="1660">
       <OrphaCode>1486</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1486</ExpertLink>
-      <Name lang="nl">Letaal congenitaal contractuursyndroom type 1</Name>
+      <Name lang="nl">Letale congenitale contracturen-syndroom type 1</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -98071,7 +97900,7 @@
     <Disorder id="16921">
       <OrphaCode>139573</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=139573</ExpertLink>
-      <Name lang="nl">Erfelijke sensorische en autonome neuropathie met doofheid en algemene achterstand</Name>
+      <Name lang="nl">Erfelijke sensorische en autonome neuropathie met doofheid en algehele achterstand</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -99176,7 +99005,7 @@
     <Disorder id="17003">
       <OrphaCode>140941</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=140941</ExpertLink>
-      <Name lang="nl">Kleine gestalte door primaire zuurlabiele subeenheiddeficiëntie</Name>
+      <Name lang="nl">Kleine gestalte door primaire deficiëntie van zuurlabiele subeenheid</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -99866,7 +99695,7 @@
     <Disorder id="1725">
       <OrphaCode>1979</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1979</ExpertLink>
-      <Name lang="nl">Lipodystrofie als gevolg van deficiëntie van peptidische groeifactoren</Name>
+      <Name lang="nl">Lipodystrofie door deficiëntie van peptidische groeifactoren</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -100746,7 +100575,7 @@
     <Disorder id="16976">
       <OrphaCode>140481</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=140481</ExpertLink>
-      <Name lang="nl">Autosomaal dominant vertraagde zenuwgeleidingssnelheid</Name>
+      <Name lang="nl">Autosomaal dominante vertraagde zenuwgeleidingssnelheid</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -105532,7 +105361,7 @@
     <Disorder id="17171">
       <OrphaCode>157997</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=157997</ExpertLink>
-      <Name lang="nl">Goedaardige cefalische histiocytose</Name>
+      <Name lang="nl">Benigne cefale histiocytose</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -105839,7 +105668,7 @@
     <Disorder id="17179">
       <OrphaCode>158025</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=158025</ExpertLink>
-      <Name lang="nl">Erfelijke progressieve mucineuze histiocytose</Name>
+      <Name lang="nl">Hereditaire progressieve mucineuze histiocytose</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -110102,7 +109931,7 @@
     <Disorder id="19529">
       <OrphaCode>247598</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=247598</ExpertLink>
-      <Name lang="nl">Neonatale intrahepatische cholestase door citrinedeficiëntie</Name>
+      <Name lang="nl">Neonatale intrahepatische cholestase door deficiëntie van citrine</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -112449,7 +112278,7 @@
     <Disorder id="19476">
       <OrphaCode>244283</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=244283</ExpertLink>
-      <Name lang="nl">Galatresie met miltmalformatiesyndroom</Name>
+      <Name lang="nl">Atresie van galwegen met malformatie van milt-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -120279,7 +120108,7 @@
     <Disorder id="19624">
       <OrphaCode>251304</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=251304</ExpertLink>
-      <Name lang="nl">Panniculitis met uveïtis en systemische granulomatose met infantiele aanvang</Name>
+      <Name lang="nl">Infantiele panniculitis met uveïtis en systemische granulomatose</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -121468,7 +121297,7 @@
     <Disorder id="2473">
       <OrphaCode>2712</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2712</ExpertLink>
-      <Name lang="nl">Oculo-facio-cardio-dentaal syndroom</Name>
+      <Name lang="nl">Oculofaciocardiodentaal syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -123038,7 +122867,7 @@
     <Disorder id="2501">
       <OrphaCode>2741</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2741</ExpertLink>
-      <Name lang="nl">Oftalmomandibulomelische dysplasie</Name>
+      <Name lang="nl">Oftalmomandibulomele dysplasie</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -130763,7 +130592,7 @@
     <Disorder id="19899">
       <OrphaCode>261652</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=261652</ExpertLink>
-      <Name lang="nl">Syndroom van Kleefstra als gevolg van een puntmutatie</Name>
+      <Name lang="nl">Syndroom van Kleefstra door puntmutatie</Name>
       <DisorderType id="21443">
         <Name lang="nl">Etiologisch subtype</Name>
       </DisorderType>
@@ -131626,7 +131455,7 @@
     <Disorder id="20068">
       <OrphaCode>263534</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=263534</ExpertLink>
-      <Name lang="nl">Acrale peeling skin-syndroom</Name>
+      <Name lang="nl">Acrale 'peeling skin'-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -134697,7 +134526,7 @@
     <Disorder id="2769">
       <OrphaCode>3086</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3086</ExpertLink>
-      <Name lang="nl">Autosomaal dominante vitreoretinale choroidopathie</Name>
+      <Name lang="nl">Autosomaal dominante vitreoretinochoroïdopathie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -138021,7 +137850,7 @@
     <Disorder id="20166">
       <OrphaCode>268129</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=268129</ExpertLink>
-      <Name lang="nl">Spheroid-body-myopathie</Name>
+      <Name lang="nl">'Spheroid body'-myopathie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -138713,7 +138542,7 @@
     <Disorder id="2571">
       <OrphaCode>2834</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2834</ExpertLink>
-      <Name lang="nl">Gerimpelde huidsyndroom</Name>
+      <Name lang="nl">Rimpelige huid-syndroom</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -141885,7 +141714,7 @@
     <Disorder id="20326">
       <OrphaCode>275761</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=275761</ExpertLink>
-      <Name lang="nl">Lysosomale zure lipasedeficiëntie</Name>
+      <Name lang="nl">Deficiëntie van lysosomale zure lipase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -144925,7 +144754,7 @@
     <Disorder id="20316">
       <OrphaCode>275523</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=275523</ExpertLink>
-      <Name lang="nl">Dianzani auto-immune lymfoproliferatieve ziekte</Name>
+      <Name lang="nl">Auto-immune lymfoproliferatieve ziekte van Dianzani</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -148633,7 +148462,7 @@
     <Disorder id="20476">
       <OrphaCode>280576</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=280576</ExpertLink>
-      <Name lang="nl">Nestor-Guillermo progeriasyndroom</Name>
+      <Name lang="nl">Progeriasyndroom van Nestor-Guillermo</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -148976,7 +148805,7 @@
     <Disorder id="20473">
       <OrphaCode>280558</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=280558</ExpertLink>
-      <Name lang="nl">Warsaw breakage-syndroom</Name>
+      <Name lang="nl">Warschau-breuksyndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -149074,7 +148903,7 @@
     <Disorder id="2875">
       <OrphaCode>3218</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3218</ExpertLink>
-      <Name lang="nl">Doofheid - epifysaire dysplasie - kleine gestalte</Name>
+      <Name lang="nl">Doofheid - epifysaire dysplasie - kleine gestalte-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -158959,7 +158788,7 @@
     <Disorder id="18687">
       <OrphaCode>210136</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=210136</ExpertLink>
-      <Name lang="nl">Longfibrose - hepatische hyperplasie - beenmerghypoplasie-syndroom</Name>
+      <Name lang="nl">Longfibrose - leverhyperplasie - beenmerghypoplasie-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -159238,7 +159067,7 @@
     <Disorder id="18675">
       <OrphaCode>209964</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=209964</ExpertLink>
-      <Name lang="nl">Solitaire rectale ulcussyndroom</Name>
+      <Name lang="nl">Solitaire rectale ulcus-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -159370,7 +159199,7 @@
     <Disorder id="18678">
       <OrphaCode>209973</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=209973</ExpertLink>
-      <Name lang="nl">Goedaardige nachtelijke alternerende hemiplegie van de kindertijd</Name>
+      <Name lang="nl">Benigne nachtelijke alternerende hemiplegie op kinderleeftijd</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -159664,7 +159493,7 @@
     <Disorder id="18665">
       <OrphaCode>209902</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=209902</ExpertLink>
-      <Name lang="nl">Hypercholesterolemie door cholesterol 7-alfa-hydroxylasedeficiëntie</Name>
+      <Name lang="nl">Hypercholesterolemie door deficiëntie van cholesterol-7-alfa-hydroxylase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -160230,6 +160059,38 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="18690">
+      <OrphaCode>210159</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=210159</ExpertLink>
+      <Name lang="nl">Volwassen hepatocellulair carcinoom</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="16523">
+          <Source>PMID: 22033323</Source>
+          <PrevalenceType id="23676">
+            <Name lang="nl">Jaarlijkse incidentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23746">
+            <Name lang="nl">1-9 / 100 000</Name>
+          </PrevalenceClass>
+          <ValMoy>3.22</ValMoy>
+          <PrevalenceGeographic id="23795">
+            <Name lang="nl">Europa</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="3523">
       <OrphaCode>3283</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3283</ExpertLink>
@@ -162177,7 +162038,7 @@
     <Disorder id="3559">
       <OrphaCode>2968</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2968</ExpertLink>
-      <Name lang="nl">Leukocytadhesiedeficiëntie</Name>
+      <Name lang="nl">Deficiëntie van leukocytenadhesie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -171897,7 +171758,7 @@
     <Disorder id="18861">
       <OrphaCode>217560</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=217560</ExpertLink>
-      <Name lang="nl">Neuro-endocriene celhyperplasie van de vroege kindertijd</Name>
+      <Name lang="nl">Hyperplasie van neuro-endocriene cellen in de zuigelingentijd</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -173654,7 +173515,7 @@
     <Disorder id="3343">
       <OrphaCode>159</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=159</ExpertLink>
-      <Name lang="nl">Carnitine-acylcarnitine translocasedeficiëntie</Name>
+      <Name lang="nl">Deficiëntie van carnitine-acylcarnitine translocase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -174750,7 +174611,7 @@
     <Disorder id="3374">
       <OrphaCode>2880</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2880</ExpertLink>
-      <Name lang="nl">Fosfo-enolpyruvaat-carboxykinasedeficiëntie</Name>
+      <Name lang="nl">Deficiëntie van fosfo-enolpyruvaat-carboxykinase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -176163,7 +176024,7 @@
     <Disorder id="18932">
       <OrphaCode>221043</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=221043</ExpertLink>
-      <Name lang="nl">Erfelijke fibroserende poikilodermie - peescontracturen - myopathie - pulmonale fibrose-syndroom</Name>
+      <Name lang="nl">Erfelijke fibroserende poikilodermie - peescontracturen - myopathie - longfibrose-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -179597,7 +179458,7 @@
     <Disorder id="3737">
       <OrphaCode>3148</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3148</ExpertLink>
-      <Name lang="nl">Maligne perifere zenuwschedetumor</Name>
+      <Name lang="nl">Maligne tumor van perifere zenuwschede</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -181340,7 +181201,7 @@
     <Disorder id="19123">
       <OrphaCode>228396</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=228396</ExpertLink>
-      <Name lang="nl">Ptose - bovenste oculaire bewegingsbeperking - afwezigheid van traanpunt-syndroom</Name>
+      <Name lang="nl">Ptosis - bovenste oculaire bewegingsbeperking - agenesie van punctum lacrimale-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -182002,7 +181863,7 @@
     <Disorder id="19096">
       <OrphaCode>228290</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=228290</ExpertLink>
-      <Name lang="nl">Witte vezelige papulose van de hals</Name>
+      <Name lang="nl">Witte vezelige papulose van hals</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -182245,7 +182106,7 @@
     <Disorder id="19102">
       <OrphaCode>228312</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=228312</ExpertLink>
-      <Name lang="nl">Auto-immune hemolytische anemie, koud type</Name>
+      <Name lang="nl">Auto-immuun hemolytische anemie, koud type</Name>
       <DisorderType id="21436">
         <Name lang="nl">Group of phenomes</Name>
       </DisorderType>
@@ -182277,7 +182138,7 @@
     <Disorder id="19088">
       <OrphaCode>228240</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=228240</ExpertLink>
-      <Name lang="nl">Elastodermie</Name>
+      <Name lang="nl">Elastoderma</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -185521,7 +185382,7 @@
     <Disorder id="19146">
       <OrphaCode>231013</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=231013</ExpertLink>
-      <Name lang="nl">Congenitale trigeminus-anesthesie</Name>
+      <Name lang="nl">Congenitale anesthesie van nervus trigeminus</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -187139,7 +187000,7 @@
     <Disorder id="19269">
       <OrphaCode>238505</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=238505</ExpertLink>
-      <Name lang="nl">Autosomaal recessieve lymfoproliferatieve ziekte</Name>
+      <Name lang="nl">Gecombineerde immuundeficiëntie door deficiëntie van CD27</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -188637,7 +188498,7 @@
     <Disorder id="21958">
       <OrphaCode>330012</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=330012</ExpertLink>
-      <Name lang="nl">Grote hoogte longoedeem</Name>
+      <Name lang="nl">Hoogtelongoedeem</Name>
       <DisorderType id="21429">
         <Name lang="nl">Particulaire klinische situatie binnen een ziekte of syndroom</Name>
       </DisorderType>
@@ -189547,7 +189408,7 @@
     <Disorder id="21924">
       <OrphaCode>329308</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=329308</ExpertLink>
-      <Name lang="nl">Vetzuurhydroxylasegeassocieerde neurodegeneratie</Name>
+      <Name lang="nl">Neurodegeneratie geassocieerd met vetzuurhydroxylase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -194397,7 +194258,7 @@
     <Disorder id="21685">
       <OrphaCode>319640</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=319640</ExpertLink>
-      <Name lang="nl">Retinale maculaire dystrofie type 2</Name>
+      <Name lang="nl">Retinale maculadystrofie type 2</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -194691,7 +194552,7 @@
     <Disorder id="21692">
       <OrphaCode>319678</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=319678</ExpertLink>
-      <Name lang="nl">Encefalopathie - hypertrofische cardiomyopathie - renale tubulaire ziekte-syndroom</Name>
+      <Name lang="nl">Encefalopathie - hypertrofische cardiomyopathie - tubulaire nierziekte-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -195311,7 +195172,7 @@
     <Disorder id="21618">
       <OrphaCode>319160</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=319160</ExpertLink>
-      <Name lang="nl">Congenitale myopathie met interne nucleï en atypische kernen</Name>
+      <Name lang="nl">Congenitale myopathie met interne nuclei en atypische kernen</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -197647,7 +197508,7 @@
     <Disorder id="22488">
       <OrphaCode>370131</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=370131</ExpertLink>
-      <Name lang="nl">White bloedplaatjessyndroom</Name>
+      <Name lang="nl">White-bloedplaatjessyndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -198968,7 +198829,7 @@
     <Disorder id="22461">
       <OrphaCode>370002</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=370002</ExpertLink>
-      <Name lang="nl">Focale palmoplantaire keratodermie met keratosen aan gewrichten</Name>
+      <Name lang="nl">Focale palmoplantaire keratodermie met keratosen van gewrichten</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -201209,7 +201070,7 @@
     <Disorder id="22382">
       <OrphaCode>364577</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=364577</ExpertLink>
-      <Name lang="nl">Intellectuele achterstand - brachydactylie - syndroom van Pierre Robin</Name>
+      <Name lang="nl">Intellectuele achterstand - brachydactylie - Pierre Robin sequentie-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -201307,7 +201168,7 @@
     <Disorder id="22298">
       <OrphaCode>363417</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=363417</ExpertLink>
-      <Name lang="nl">Temtamy preaxiale brachydactylie-syndroom</Name>
+      <Name lang="nl">Preaxiale brachydactylie van Temtamy-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -201454,7 +201315,7 @@
     <Disorder id="22302">
       <OrphaCode>363429</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=363429</ExpertLink>
-      <Name lang="nl">Autosomaal recessieve cerebellaire ataxie - piramidale tekenen - nystagmus - oculomotorische apraxie-syndroom</Name>
+      <Name lang="nl">Autosomaal recessieve cerebellaire ataxie - piramidale verschijnselen - nystagmus - oculomotorische apraxie-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -204409,7 +204270,7 @@
     <Disorder id="22091">
       <OrphaCode>352649</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=352649</ExpertLink>
-      <Name lang="nl">Defect van het vesiculair transport van dopamine en serotonine in de hersenen</Name>
+      <Name lang="nl">Defect van vesiculair transport van dopamine en serotonine in hersenen</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -205225,7 +205086,7 @@
     <Disorder id="22126">
       <OrphaCode>353253</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=353253</ExpertLink>
-      <Name lang="nl">Brandendemondsyndroom</Name>
+      <Name lang="nl">Syndroom van mondbranden</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -206186,7 +206047,7 @@
     <Disorder id="20900">
       <OrphaCode>293987</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=293987</ExpertLink>
-      <Name lang="nl">Snel aanvangende obesitas in de kindertijd - hypothalamische disfunctie - hypoventilatie - autonome disregulatie-syndroom</Name>
+      <Name lang="nl">Snel aanvangende obesitas in de kindertijd - disfunctie van hypothalamus - hypoventilatie - autonome disregulatie-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -206480,7 +206341,7 @@
     <Disorder id="20898">
       <OrphaCode>293978</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=293978</ExpertLink>
-      <Name lang="nl">Deficiëntie van de voorste hypofysefunctie - variabele immuundeficiëntie-syndroom</Name>
+      <Name lang="nl">Disfunctie van adenohypofyse - variabele immuundeficiëntie-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -206578,7 +206439,7 @@
     <Disorder id="20894">
       <OrphaCode>293955</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=293955</ExpertLink>
-      <Name lang="nl">Encefalopathie in de kindertijd door thiaminepyrofosfokinasedeficiëntie</Name>
+      <Name lang="nl">Encefalopathie in de kindertijd door deficiëntie van thiaminepyrofosfokinase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -208120,7 +207981,7 @@
     <Disorder id="20839">
       <OrphaCode>293168</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=293168</ExpertLink>
-      <Name lang="nl">Toenemende erfelijke spastische paralyse met aanvang tijdens de vroege kindertijd</Name>
+      <Name lang="nl">Opstijgende erfelijke spastische paralyse met infantiele aanvang</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -209196,19 +209057,19 @@
       </DisorderGroup>
       <PrevalenceList count="1">
         <Prevalence id="5002">
-          <Source>[EXPERT]_European Medicines Agency[INST]</Source>
+          <Source>ORPHANET</Source>
           <PrevalenceType id="23669">
             <Name lang="nl">Puntprevalentie</Name>
           </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
           </PrevalenceQualification>
-          <PrevalenceClass id="23732">
-            <Name lang="nl">1-5 / 10 000</Name>
+          <PrevalenceClass id="23774">
+            <Name lang="nl">Unknown</Name>
           </PrevalenceClass>
-          <ValMoy>11.0</ValMoy>
-          <PrevalenceGeographic id="23795">
-            <Name lang="nl">Europa</Name>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
           </PrevalenceGeographic>
           <PrevalenceValidationStatus id="25958">
             <Name lang="nl">Validated</Name>
@@ -211096,7 +210957,7 @@
     <Disorder id="20530">
       <OrphaCode>281139</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=281139</ExpertLink>
-      <Name lang="nl">Ringvormige epidermolytische ichthyosis</Name>
+      <Name lang="nl">Annulaire epidermolytische ichthyosis</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -212624,7 +212485,7 @@
     <Disorder id="20603">
       <OrphaCode>284388</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=284388</ExpertLink>
-      <Name lang="nl">Reversibele cerebrale vasoconstrictiesyndroom</Name>
+      <Name lang="nl">Reversibele cerebrale vasoconstrictie-syndroom</Name>
       <DisorderType id="21422">
         <Name lang="nl">Klinisch syndroom</Name>
       </DisorderType>
@@ -213917,7 +213778,7 @@
     <Disorder id="21496">
       <OrphaCode>314572</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=314572</ExpertLink>
-      <Name lang="nl">Autosomaal recessief leuko-encefalopathie - ischemische beroerte - retinitis pigmentosa-syndroom</Name>
+      <Name lang="nl">Autosomaal recessieve leuko-encefalopathie - ischemische beroerte - retinitis pigmentosa-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -214015,7 +213876,7 @@
     <Disorder id="21498">
       <OrphaCode>314585</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=314585</ExpertLink>
-      <Name lang="nl">15q overgroeisyndroom</Name>
+      <Name lang="nl">15q-overgroeisyndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -214959,7 +214820,7 @@
     <Disorder id="21475">
       <OrphaCode>314051</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=314051</ExpertLink>
-      <Name lang="nl">Leuko-encefalopathie - thalamus- en hersenstamanomalieën - hoog lactaatgehalte-syndroom</Name>
+      <Name lang="nl">Leuko-encefalopathie - anomalieën van thalamus en hersenstam - hoog lactaatgehalte-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -215300,7 +215161,7 @@
     <Disorder id="21310">
       <OrphaCode>308410</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=308410</ExpertLink>
-      <Name lang="nl">Autisme-epilepsiesyndroom door vertakte keten-ketozuurdehydrogenasekinasedeficiëntie</Name>
+      <Name lang="nl">Autisme - epilepsie-syndroom door deficiëntie van vertakte keten-ketozuurdehydrogenasekinase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -215496,7 +215357,7 @@
     <Disorder id="21342">
       <OrphaCode>309111</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=309111</ExpertLink>
-      <Name lang="nl">Gecombineerde pancreatische lipase-colipasedeficiëntie</Name>
+      <Name lang="nl">Gecombineerde deficiëntie van pancreatisch lipase-colipase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -215545,7 +215406,7 @@
     <Disorder id="21341">
       <OrphaCode>309108</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=309108</ExpertLink>
-      <Name lang="nl">Pancreatische colipasedeficiëntie</Name>
+      <Name lang="nl">Deficiëntie van pancreatisch colipase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -215643,7 +215504,7 @@
     <Disorder id="21336">
       <OrphaCode>309015</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=309015</ExpertLink>
-      <Name lang="nl">Familiale lipoproteïnelipasedeficiëntie</Name>
+      <Name lang="nl">Familiale deficiëntie van lipoproteïnelipase</Name>
       <DisorderType id="21443">
         <Name lang="nl">Etiologisch subtype</Name>
       </DisorderType>
@@ -216758,7 +216619,7 @@
     <Disorder id="21130">
       <OrphaCode>300557</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=300557</ExpertLink>
-      <Name lang="nl">Carcinoom van de ampul van Vater</Name>
+      <Name lang="nl">Carcinoom van ampul van Vater</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -217382,7 +217243,7 @@
     <Disorder id="21146">
       <OrphaCode>300857</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=300857</ExpertLink>
-      <Name lang="nl">T-cel/histiocyt-rijk grootcellig B-cellymfoom</Name>
+      <Name lang="nl">T-cel/histiocytenrijk grootcellig B-cellymfoom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -217753,7 +217614,7 @@
     <Disorder id="21153">
       <OrphaCode>300912</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=300912</ExpertLink>
-      <Name lang="nl">Marginale zone-lymfoom</Name>
+      <Name lang="nl">Marginale zone lymfoom</Name>
       <DisorderType id="21436">
         <Name lang="nl">Group of phenomes</Name>
       </DisorderType>
@@ -218230,7 +218091,7 @@
     <Disorder id="21218">
       <OrphaCode>306498</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=306498</ExpertLink>
-      <Name lang="nl">PTEN-hamartoomtumorsyndroom</Name>
+      <Name lang="nl">PTEN-hamartoom-tumorsyndroom</Name>
       <DisorderType id="21436">
         <Name lang="nl">Group of phenomes</Name>
       </DisorderType>
@@ -220267,7 +220128,7 @@
     <Disorder id="24021">
       <OrphaCode>464343</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=464343</ExpertLink>
-      <Name lang="nl">Catastrofaal antifosfolipidesyndroom</Name>
+      <Name lang="nl">Catastrofaal antifosfolipidensyndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -225645,7 +225506,7 @@
     <Disorder id="24185">
       <OrphaCode>466962</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=466962</ExpertLink>
-      <Name lang="nl">SMARCA4-deficiënt sarcoom van de thorax</Name>
+      <Name lang="nl">SMARCA4-deficiënt sarcoom van thorax</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -228948,7 +228809,7 @@
     <Disorder id="22857">
       <OrphaCode>401948</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=401948</ExpertLink>
-      <Name lang="nl">Hyperammoniëmische encefalopathie door carboanhydrase VA-deficiëntie</Name>
+      <Name lang="nl">Hyperammoniëmische encefalopathie door deficiëntie van koolzuuranhydrase VA</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -229666,7 +229527,7 @@
     <Disorder id="22925">
       <OrphaCode>404466</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=404466</ExpertLink>
-      <Name lang="nl">Vrouwelijke onvruchtbaarheid door zona pellucida-defect</Name>
+      <Name lang="nl">Vrouwelijke infertiliteit door defect van zona pellucida</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -230463,7 +230324,7 @@
     <Disorder id="23021">
       <OrphaCode>411593</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=411593</ExpertLink>
-      <Name lang="nl">Insuline auto-immuun syndroom</Name>
+      <Name lang="nl">Insuline-auto-immuun syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -232507,7 +232368,7 @@
     <Disorder id="22603">
       <OrphaCode>391316</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=391316</ExpertLink>
-      <Name lang="nl">Mesiale temporaalkwabepilepsie met ernstige cognitieve regressie met infantiele aanvang</Name>
+      <Name lang="nl">Infantiele mesiale temporaalkwabepilepsie met ernstige cognitieve regressie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -232606,11 +232467,11 @@
       <OrphaCode>391320</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=391320</ExpertLink>
       <Name lang="nl">Oost-Texas-bloedingsstoornis</Name>
-      <DisorderType id="21394">
-        <Name lang="nl">Ziekte</Name>
+      <DisorderType id="21443">
+        <Name lang="nl">Etiologisch subtype</Name>
       </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
+      <DisorderGroup id="36554">
+        <Name lang="nl">Subtype van aandoening</Name>
       </DisorderGroup>
       <PrevalenceList count="2">
         <Prevalence id="10512">
@@ -234089,7 +233950,7 @@
     <Disorder id="22705">
       <OrphaCode>397927</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=397927</ExpertLink>
-      <Name lang="nl">Sacrale agenesie - abnormale ossificatie van de wervellichamen - persisterende chorda dorsalis-syndroom</Name>
+      <Name lang="nl">Sacrale agenesie - abnormale ossificatie van wervellichamen - persisterende chorda dorsalis-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -234236,7 +234097,7 @@
     <Disorder id="22700">
       <OrphaCode>397755</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=397755</ExpertLink>
-      <Name lang="nl">Periodieke verlamming met voorbijgaand compartimentachtig syndroom</Name>
+      <Name lang="nl">Periodieke paralyse met voorbijgaand compartimentachtig syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -234383,7 +234244,7 @@
     <Disorder id="22699">
       <OrphaCode>397750</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=397750</ExpertLink>
-      <Name lang="nl">Periodieke verlamming met later aanvangende distale motorneuropathie</Name>
+      <Name lang="nl">Periodieke paralyse met later optredende distale motorische neuropathie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -234937,7 +234798,7 @@
     <Disorder id="22684">
       <OrphaCode>397593</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=397593</ExpertLink>
-      <Name lang="nl">Ernstige neonatale melkzuuracidose door NFS1-ISD11-complexdeficiëntie</Name>
+      <Name lang="nl">Ernstige neonatale lactaatacidose door deficiëntie van NFS1-ISD11-complex</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -235747,7 +235608,7 @@
     <Disorder id="22747">
       <OrphaCode>399086</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=399086</ExpertLink>
-      <Name lang="nl">Finse distale myopathie met aanvang in de bovenste ledematen</Name>
+      <Name lang="nl">Distale myopathie met aanvang in bovenste ledematen, Fins type</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -237588,7 +237449,7 @@
     <Disorder id="22726">
       <OrphaCode>398109</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=398109</ExpertLink>
-      <Name lang="nl">Neonatale auto-immune hemolytische anemie</Name>
+      <Name lang="nl">Neonatale auto-immuun hemolytische anemie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -240744,8 +240605,46 @@
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="1">
-        <Prevalence id="5081">
+      <PrevalenceList count="5">
+        <Prevalence id="16532">
+          <Source>PMID: 21039677</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23746">
+            <Name lang="nl">1-9 / 100 000</Name>
+          </PrevalenceClass>
+          <ValMoy>3.7</ValMoy>
+          <PrevalenceGeographic id="25335">
+            <Name lang="nl">Sweden</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="16533">
+          <Source>PMID: 21039677</Source>
+          <PrevalenceType id="23676">
+            <Name lang="nl">Jaarlijkse incidentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23739">
+            <Name lang="nl">1-9 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.7</ValMoy>
+          <PrevalenceGeographic id="25335">
+            <Name lang="nl">Sweden</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="16534">
           <Source>ORPHANET</Source>
           <PrevalenceType id="23669">
             <Name lang="nl">Puntprevalentie</Name>
@@ -240753,15 +240652,51 @@
           <PrevalenceQualification id="23704">
             <Name lang="nl">Class only</Name>
           </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="nl">Unknown</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23795">
+            <Name lang="nl">Europa</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="16535">
+          <Source>PMID: 28180235</Source>
+          <PrevalenceType id="23676">
+            <Name lang="nl">Jaarlijkse incidentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>2.75</ValMoy>
+          <PrevalenceGeographic id="24607">
+            <Name lang="nl">Italy</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="16536">
+          <Source>PMID: 21039677 ; 28180235</Source>
+          <PrevalenceType id="23676">
+            <Name lang="nl">Jaarlijkse incidentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
           <PrevalenceClass id="23746">
             <Name lang="nl">1-9 / 100 000</Name>
           </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
+          <ValMoy>1.72</ValMoy>
           <PrevalenceGeographic id="23795">
             <Name lang="nl">Europa</Name>
           </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25965">
-            <Name lang="nl">Not yet validated</Name>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
       </PrevalenceList>
@@ -241755,7 +241690,7 @@
     <Disorder id="23490">
       <OrphaCode>444463</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=444463</ExpertLink>
-      <Name lang="nl">Auto-immune hemolytische anemie - auto-immune trombocytopenie - primaire immuundeficiëntie-syndroom</Name>
+      <Name lang="nl">Auto-immuun hemolytische anemie - auto-immuun trombocytopenie - primaire immuundeficiëntie-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -244637,7 +244572,7 @@
     <Disorder id="23104">
       <OrphaCode>420402</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=420402</ExpertLink>
-      <Name lang="nl">Semicirculair kanaal-dehiscentiesyndroom</Name>
+      <Name lang="nl">Dehiscentie van canalis semicircularis-syndroom</Name>
       <DisorderType id="21422">
         <Name lang="nl">Klinisch syndroom</Name>
       </DisorderType>
@@ -246159,7 +246094,7 @@
     <Disorder id="23197">
       <OrphaCode>424107</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=424107</ExpertLink>
-      <Name lang="nl">Congenitale myopathie met myastheenachtige aanvang</Name>
+      <Name lang="nl">Congenitale myopathie met myasthenie-achtige aanvang</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -253991,7 +253926,7 @@
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
       <PrevalenceList count="1">
-        <Prevalence id="5325">
+        <Prevalence id="16531">
           <Source>ORPHANET</Source>
           <PrevalenceType id="23669">
             <Name lang="nl">Puntprevalentie</Name>
@@ -253999,15 +253934,15 @@
           <PrevalenceQualification id="23704">
             <Name lang="nl">Class only</Name>
           </PrevalenceQualification>
-          <PrevalenceClass id="23732">
-            <Name lang="nl">1-5 / 10 000</Name>
+          <PrevalenceClass id="23774">
+            <Name lang="nl">Unknown</Name>
           </PrevalenceClass>
           <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23795">
-            <Name lang="nl">Europa</Name>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
           </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25965">
-            <Name lang="nl">Not yet validated</Name>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
       </PrevalenceList>
@@ -254023,37 +253958,39 @@
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
       <PrevalenceList count="2">
-        <Prevalence id="5326">
-          <Source>28233358[PMID]</Source>
-          <PrevalenceType id="23697">
-            <Name lang="nl">Cases/families</Name>
+        <Prevalence id="16527">
+          <Source>PMID: 24616761</Source>
+          <PrevalenceType id="23683">
+            <Name lang="nl">Geboorteprevalentie</Name>
           </PrevalenceType>
-          <PrevalenceQualification id="23718">
-            <Name lang="nl">Case</Name>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
           </PrevalenceQualification>
-          <PrevalenceClass/>
-          <ValMoy>107.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
+          <PrevalenceClass id="23746">
+            <Name lang="nl">1-9 / 100 000</Name>
+          </PrevalenceClass>
+          <ValMoy>2.12</ValMoy>
+          <PrevalenceGeographic id="25475">
+            <Name lang="nl">United Kingdom</Name>
           </PrevalenceGeographic>
           <PrevalenceValidationStatus id="25958">
             <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
-        <Prevalence id="5327">
-          <Source>ORPHANET_28233358[PMID]</Source>
+        <Prevalence id="16537">
+          <Source>ORPHANET</Source>
           <PrevalenceType id="23669">
             <Name lang="nl">Puntprevalentie</Name>
           </PrevalenceType>
           <PrevalenceQualification id="23704">
             <Name lang="nl">Class only</Name>
           </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          <PrevalenceClass id="23774">
+            <Name lang="nl">Unknown</Name>
           </PrevalenceClass>
           <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
+          <PrevalenceGeographic id="23795">
+            <Name lang="nl">Europa</Name>
           </PrevalenceGeographic>
           <PrevalenceValidationStatus id="25958">
             <Name lang="nl">Validated</Name>
@@ -261261,7 +261198,7 @@
     <Disorder id="26030">
       <OrphaCode>500464</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=500464</ExpertLink>
-      <Name lang="nl">Plaveiselcelcarcinoom van de neusholte en neusbijholten</Name>
+      <Name lang="nl">Plaveiselcelcarcinoom van neusholte en neusbijholten</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -263273,7 +263210,7 @@
     <Disorder id="8697">
       <OrphaCode>721</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=721</ExpertLink>
-      <Name lang="nl">Grijze bloedplaatjessyndroom</Name>
+      <Name lang="nl">Grijze-bloedplaatjessyndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -263331,7 +263268,7 @@
       </DisorderGroup>
       <PrevalenceList count="1">
         <Prevalence id="5280">
-          <Source>European Medicines Agency 2015[INST]</Source>
+          <Source>PMID: 32001536</Source>
           <PrevalenceType id="23669">
             <Name lang="nl">Puntprevalentie</Name>
           </PrevalenceType>
@@ -263341,7 +263278,7 @@
           <PrevalenceClass id="23739">
             <Name lang="nl">1-9 / 1 000 000</Name>
           </PrevalenceClass>
-          <ValMoy>0.2</ValMoy>
+          <ValMoy>0.16</ValMoy>
           <PrevalenceGeographic id="23795">
             <Name lang="nl">Europa</Name>
           </PrevalenceGeographic>
@@ -266213,7 +266150,7 @@
     <Disorder id="8618">
       <OrphaCode>658</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=658</ExpertLink>
-      <Name lang="nl">Niet-histaminisch angio-oedeem</Name>
+      <Name lang="nl">Niet-histamine-geïnduceerd angio-oedeem</Name>
       <DisorderType id="21436">
         <Name lang="nl">Group of phenomes</Name>
       </DisorderType>
@@ -269230,7 +269167,7 @@
     <Disorder id="25178">
       <OrphaCode>478664</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=478664</ExpertLink>
-      <Name lang="nl">Congenitale ongevoeligheid voor pijn - hypohidrose-syndroom</Name>
+      <Name lang="nl">Erfelijke sensorische en autonome neuropathie type 8</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -271948,7 +271885,7 @@
     <Disorder id="10987">
       <OrphaCode>71212</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=71212</ExpertLink>
-      <Name lang="nl">Hyperinsulinisme als gevolg van korte keten 3-hydroxylacyl-CoA-dehydrogenasedeficiëntie</Name>
+      <Name lang="nl">Hyperinsulinisme door deficiëntie van korte-keten-3-hydroxylacyl-CoA-dehydrogenase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -272751,7 +272688,26 @@
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="3">
+      <PrevalenceList count="4">
+        <Prevalence id="16526">
+          <Source>EXPERT</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="nl">Unknown</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
         <Prevalence id="16440">
           <Source>PMID: 28356407</Source>
           <PrevalenceType id="23676">
@@ -276226,7 +276182,7 @@
     <Disorder id="10887">
       <OrphaCode>66629</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=66629</ExpertLink>
-      <Name lang="nl">Goldberg-Shprintzen megacolonsyndroom</Name>
+      <Name lang="nl">Megacolonsyndroom van Goldberg-Shprintzen</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -276537,7 +276493,7 @@
     <Disorder id="10880">
       <OrphaCode>65798</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=65798</ExpertLink>
-      <Name lang="nl">Goodmansyndroom</Name>
+      <Name lang="nl">Syndroom van Goodman</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -276603,7 +276559,7 @@
             <Name lang="nl">Case</Name>
           </PrevalenceQualification>
           <PrevalenceClass/>
-          <ValMoy>20.0</ValMoy>
+          <ValMoy>49.0</ValMoy>
           <PrevalenceGeographic id="23844">
             <Name lang="nl">Wereldwijd</Name>
           </PrevalenceGeographic>
@@ -277956,7 +277912,7 @@
     <Disorder id="10843">
       <OrphaCode>64739</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=64739</ExpertLink>
-      <Name lang="nl">Ovariumhyperstimulatiesyndroom</Name>
+      <Name lang="nl">Ovarieel hyperstimulatiesyndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -279962,7 +279918,7 @@
     <Disorder id="10782">
       <OrphaCode>59135</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=59135</ExpertLink>
-      <Name lang="nl">Laing distale myopathie met vroege aanvang</Name>
+      <Name lang="nl">Distale myopathie met vroege aanvang, Laing-type</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -282563,7 +282519,7 @@
     <Disorder id="11194">
       <OrphaCode>79168</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=79168</ExpertLink>
-      <Name lang="nl">Defect van galzuursynthese</Name>
+      <Name lang="nl">Aandoening van galzuursynthese</Name>
       <DisorderType id="36561">
         <Name lang="nl">Category</Name>
       </DisorderType>
@@ -282906,7 +282862,7 @@
     <Disorder id="11150">
       <OrphaCode>79113</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=79113</ExpertLink>
-      <Name lang="nl">Mandibulofaciale dysostose-microcefaliesyndroom</Name>
+      <Name lang="nl">Mandibulofaciale dysostose - microcefalie-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -283232,7 +283188,7 @@
     <Disorder id="11137">
       <OrphaCode>79095</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=79095</ExpertLink>
-      <Name lang="nl">Congenitaal galzuursynthesedefect type 4</Name>
+      <Name lang="nl">Congenitaal defect van galzuursynthese type 4</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -287098,7 +287054,7 @@
     <Disorder id="11048">
       <OrphaCode>73272</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=73272</ExpertLink>
-      <Name lang="nl">Groeiachterstand als gevolg van insuline-achtige groeifactor I-deficiëntie</Name>
+      <Name lang="nl">Groeiachterstand door deficiëntie van insulineachtige groeifactor I</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -287147,7 +287103,7 @@
     <Disorder id="11049">
       <OrphaCode>73273</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=73273</ExpertLink>
-      <Name lang="nl">Groeiachterstand door insuline-achtige groeifactor I-resistentie</Name>
+      <Name lang="nl">Groeiachterstand door insulineachtige groeifactor I-resistentie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -287673,7 +287629,7 @@
     <Disorder id="11011">
       <OrphaCode>71289</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=71289</ExpertLink>
-      <Name lang="nl">Radio-ulnaire synostose - amegakaryocytische trombocytopenie-syndroom</Name>
+      <Name lang="nl">Radio-ulnaire synostose - amegakaryocytaire trombocytopenie-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -287771,7 +287727,7 @@
     <Disorder id="11021">
       <OrphaCode>71528</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=71528</ExpertLink>
-      <Name lang="nl">Obesitas als gevolg van prohormoonconvertase-I-deficiëntie</Name>
+      <Name lang="nl">Obesitas door deficiëntie van prohormoonconvertase I</Name>
       <DisorderType id="21443">
         <Name lang="nl">Etiologisch subtype</Name>
       </DisorderType>
@@ -287820,7 +287776,7 @@
     <Disorder id="11022">
       <OrphaCode>71529</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=71529</ExpertLink>
-      <Name lang="nl">Obesitas als gevolg van melanocortine-4-receptordeficiëntie</Name>
+      <Name lang="nl">Obesitas door deficiëntie van melanocortine 4-receptor</Name>
       <DisorderType id="21443">
         <Name lang="nl">Etiologisch subtype</Name>
       </DisorderType>
@@ -289983,7 +289939,7 @@
     <Disorder id="10380">
       <OrphaCode>35656</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=35656</ExpertLink>
-      <Name lang="nl">Co-enzym Q10-deficiëntie</Name>
+      <Name lang="nl">Deficiëntie van co-enzym Q10</Name>
       <DisorderType id="21436">
         <Name lang="nl">Group of phenomes</Name>
       </DisorderType>
@@ -290209,7 +290165,7 @@
     <Disorder id="10424">
       <OrphaCode>36387</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=36387</ExpertLink>
-      <Name lang="nl">Gegeneraliseerde epilepsie met febriele aanvallen - plus</Name>
+      <Name lang="nl">Gegeneraliseerde epilepsie met febriele aanvallen plus</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -300134,7 +300090,7 @@
     <Disorder id="28070">
       <OrphaCode>544254</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=544254</ExpertLink>
-      <Name lang="nl">SYNGAP1-gerelateerde ontwikkelings- en epileptische encefalopathie</Name>
+      <Name lang="nl">SYNGAP1-gerelateerde ontwikkelingsachterstand en epileptische encefalopathie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -303007,7 +302963,7 @@
     <Disorder id="11934">
       <OrphaCode>90037</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=90037</ExpertLink>
-      <Name lang="nl">Geneesmiddel-geïnduceerde auto-immune hemolytische anemie</Name>
+      <Name lang="nl">Geneesmiddelgeïnduceerde auto-immuun hemolytische anemie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -303122,7 +303078,7 @@
     <Disorder id="11933">
       <OrphaCode>90036</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=90036</ExpertLink>
-      <Name lang="nl">Auto-immune hemolytische anemie van het gemengde type</Name>
+      <Name lang="nl">Auto-immuun hemolytische anemie, gemengd type</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -303203,7 +303159,7 @@
     <Disorder id="11931">
       <OrphaCode>90033</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=90033</ExpertLink>
-      <Name lang="nl">Auto-immune hemolytische anemie, warm type</Name>
+      <Name lang="nl">Auto-immuun hemolytische anemie, warm type</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -303731,7 +303687,7 @@
     <Disorder id="12020">
       <OrphaCode>90342</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=90342</ExpertLink>
-      <Name lang="nl">Xeroderma pigmentosum variant</Name>
+      <Name lang="nl">Xeroderma pigmentosum, variante vorm</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -307762,7 +307718,7 @@
     <Disorder id="12199">
       <OrphaCode>93256</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=93256</ExpertLink>
-      <Name lang="nl">Fragiele X-geassocieerd tremor/ataxie-syndroom</Name>
+      <Name lang="nl">Fragiele-X-geassocieerd tremor/ataxie-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -308998,15 +308954,15 @@
           <PrevalenceQualification id="23704">
             <Name lang="nl">Class only</Name>
           </PrevalenceQualification>
-          <PrevalenceClass id="23739">
-            <Name lang="nl">1-9 / 1 000 000</Name>
+          <PrevalenceClass id="23774">
+            <Name lang="nl">Unknown</Name>
           </PrevalenceClass>
           <ValMoy>0.0</ValMoy>
           <PrevalenceGeographic id="23795">
             <Name lang="nl">Europa</Name>
           </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25965">
-            <Name lang="nl">Not yet validated</Name>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
       </PrevalenceList>
@@ -311467,7 +311423,7 @@
     <Disorder id="12138">
       <OrphaCode>91387</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=91387</ExpertLink>
-      <Name lang="nl">Familiaal thoracaal aorta-aneurysma</Name>
+      <Name lang="nl">Familiale dissectie en aneurysma van thoracale aorta</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -311850,7 +311806,7 @@
     <Disorder id="12133">
       <OrphaCode>91359</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=91359</ExpertLink>
-      <Name lang="nl">Chronische pneumonitis in de kinderjaren</Name>
+      <Name lang="nl">Chronische pneumonitis op zuigelingenleeftijd</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -312934,7 +312890,7 @@
     <Disorder id="12100">
       <OrphaCode>90797</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=90797</ExpertLink>
-      <Name lang="nl">Gedeeltelijke androgeenongevoeligheidssyndroom</Name>
+      <Name lang="nl">Partieel androgeenongevoeligheidssyndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -313295,7 +313251,7 @@
     <Disorder id="12112">
       <OrphaCode>91135</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=91135</ExpertLink>
-      <Name lang="nl">Hyperlaxiteit van de lichaamshuid door deficiëntie van vitamine K-afhankelijke coagulatiefactor</Name>
+      <Name lang="nl">Hyperlaxiteit van huid door deficiëntie van vitamine K-afhankelijke coagulatiefactor</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -317052,7 +317008,7 @@
     <Disorder id="11327">
       <OrphaCode>79301</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=79301</ExpertLink>
-      <Name lang="nl">Congenitaal galzuursynthesedefect type 1</Name>
+      <Name lang="nl">Congenitaal defect van galzuursynthese type 1</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -317613,7 +317569,7 @@
     <Disorder id="11305">
       <OrphaCode>79279</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=79279</ExpertLink>
-      <Name lang="nl">Alfa-N-acetylgalactosaminidasedeficiëntie type 1</Name>
+      <Name lang="nl">Deficiëntie van alfa-N-acetylgalactosaminidase type 1</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -317662,7 +317618,7 @@
     <Disorder id="11306">
       <OrphaCode>79280</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=79280</ExpertLink>
-      <Name lang="nl">Alfa-N-acetylgalactosaminidasedeficiëntie type 2</Name>
+      <Name lang="nl">Deficiëntie van alfa-N-acetylgalactosaminidase type 2</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -317711,7 +317667,7 @@
     <Disorder id="11307">
       <OrphaCode>79281</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=79281</ExpertLink>
-      <Name lang="nl">Alfa-N-acetylgalactosaminidasedeficiëntie type 3</Name>
+      <Name lang="nl">Deficiëntie van alfa-N-acetylgalactosaminidase type 3</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -319791,7 +319747,7 @@
     <Disorder id="11328">
       <OrphaCode>79302</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=79302</ExpertLink>
-      <Name lang="nl">Congenitaal galzuursynthesedefect type 3</Name>
+      <Name lang="nl">Congenitaal defect van galzuursynthese type 3</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -319840,7 +319796,7 @@
     <Disorder id="11329">
       <OrphaCode>79303</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=79303</ExpertLink>
-      <Name lang="nl">Congenitaal galzuursynthesedefect type 2</Name>
+      <Name lang="nl">Congenitaal defect van galzuursynthese type 2</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -319980,7 +319936,7 @@
     <Disorder id="11377">
       <OrphaCode>79351</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=79351</ExpertLink>
-      <Name lang="nl">3-Fosfoglyceraatdehydrogenasedeficiëntie, infantiele/juveniele vorm</Name>
+      <Name lang="nl">Deficiëntie van 3-fosfoglyceraatdehydrogenase, infantiele/juveniele vorm</Name>
       <DisorderType id="21443">
         <Name lang="nl">Etiologisch subtype</Name>
       </DisorderType>
@@ -320029,7 +319985,7 @@
     <Disorder id="11376">
       <OrphaCode>79350</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=79350</ExpertLink>
-      <Name lang="nl">3-fosfoserinefosfatasedeficiëntie, infantiele/juveniele vorm</Name>
+      <Name lang="nl">Deficiëntie van 3-fosfoserinefosfatase, infantiele/juveniele vorm</Name>
       <DisorderType id="21443">
         <Name lang="nl">Etiologisch subtype</Name>
       </DisorderType>
@@ -320272,7 +320228,7 @@
     <Disorder id="11650">
       <OrphaCode>85192</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=85192</ExpertLink>
-      <Name lang="nl">Calvariale donutlaesies - botfragiliteit</Name>
+      <Name lang="nl">Donutlaesies van calvaria - botfragiliteit-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -320568,7 +320524,7 @@
     <Disorder id="11661">
       <OrphaCode>85203</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=85203</ExpertLink>
-      <Name lang="nl">Acro-pectoraal syndroom</Name>
+      <Name lang="nl">Acropectoraal syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -321759,7 +321715,7 @@
     <Disorder id="11691">
       <OrphaCode>85321</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=85321</ExpertLink>
-      <Name lang="nl">Doofheid - intellectuele achterstand, Martin-Probst-type</Name>
+      <Name lang="nl">Doofheid - intellectuele achterstand-syndroom, Martin-Probst-type</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -322807,26 +322763,7 @@
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="2">
-        <Prevalence id="6829">
-          <Source>23148499[PMID]</Source>
-          <PrevalenceType id="23676">
-            <Name lang="nl">Jaarlijkse incidentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23739">
-            <Name lang="nl">1-9 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.1</ValMoy>
-          <PrevalenceGeographic id="25335">
-            <Name lang="nl">Sweden</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
+      <PrevalenceList count="1">
         <Prevalence id="10620">
           <Source>ORPHANET</Source>
           <PrevalenceType id="23669">
@@ -322835,15 +322772,15 @@
           <PrevalenceQualification id="23704">
             <Name lang="nl">Class only</Name>
           </PrevalenceQualification>
-          <PrevalenceClass id="23732">
-            <Name lang="nl">1-5 / 10 000</Name>
+          <PrevalenceClass id="23774">
+            <Name lang="nl">Unknown</Name>
           </PrevalenceClass>
           <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23795">
-            <Name lang="nl">Europa</Name>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
           </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25965">
-            <Name lang="nl">Not yet validated</Name>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
       </PrevalenceList>
@@ -323502,7 +323439,7 @@
     <Disorder id="11734">
       <OrphaCode>86814</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=86814</ExpertLink>
-      <Name lang="nl">Goedaardige familiale myoclonische epilepsie, volwassen vorm</Name>
+      <Name lang="nl">Goedaardige adulte familiale myoclonische epilepsie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -324386,7 +324323,7 @@
     <Disorder id="11757">
       <OrphaCode>86852</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=86852</ExpertLink>
-      <Name lang="nl">B-cel prolymfocytische leukemie</Name>
+      <Name lang="nl">B-cel-prolymfocytenleukemie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -324565,7 +324502,7 @@
     <Disorder id="11766">
       <OrphaCode>86872</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=86872</ExpertLink>
-      <Name lang="nl">T-cel-leukemie met grote granulaire lymfocyten</Name>
+      <Name lang="nl">Grootcellige granulaire lymfocytaire T-celleukemie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -324680,7 +324617,7 @@
     <Disorder id="11762">
       <OrphaCode>86867</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=86867</ExpertLink>
-      <Name lang="nl">Nodaal marginaal zone B-cellymfoom</Name>
+      <Name lang="nl">Nodaal marginale zone B-cellymfoom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -325277,7 +325214,7 @@
     <Disorder id="11770">
       <OrphaCode>86880</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=86880</ExpertLink>
-      <Name lang="nl">Enteropathiegeassocieerd T-cellymfoom</Name>
+      <Name lang="nl">Enteropathie-geassocieerd T-cellymfoom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -333287,7 +333224,7 @@
     <Disorder id="12654">
       <OrphaCode>95699</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=95699</ExpertLink>
-      <Name lang="nl">Congenitale adrenale hyperplasie als gevolg van cytochroom P450-oxidoreductasedeficiëntie</Name>
+      <Name lang="nl">Congenitale hyperplasie van bijnier door deficiëntie van cytochroom P450-oxidoreductase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -333402,7 +333339,7 @@
     <Disorder id="12620">
       <OrphaCode>95496</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=95496</ExpertLink>
-      <Name lang="nl">Hypofysesteelonderbrekingsyndroom</Name>
+      <Name lang="nl">Syndroom van onderbreking van hypofysesteel</Name>
       <DisorderType id="21415">
         <Name lang="nl">Morfologische anomalie</Name>
       </DisorderType>
@@ -334301,7 +334238,7 @@
     <Disorder id="12544">
       <OrphaCode>94063</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=94063</ExpertLink>
-      <Name lang="nl">12q14 microdeletiesyndroom</Name>
+      <Name lang="nl">12q14-microdeletiesyndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -335083,7 +335020,7 @@
     <Disorder id="12771">
       <OrphaCode>96147</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=96147</ExpertLink>
-      <Name lang="nl">Kleefstrasyndroom als gevolg van 9q34 microdeletie</Name>
+      <Name lang="nl">Syndroom van Kleefstra door 9q34-microdeletie</Name>
       <DisorderType id="21443">
         <Name lang="nl">Etiologisch subtype</Name>
       </DisorderType>
@@ -338879,7 +338816,7 @@
     <Disorder id="12439">
       <OrphaCode>93606</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=93606</ExpertLink>
-      <Name lang="nl">Nefrogeen syndroom van ongepaste antidiurese</Name>
+      <Name lang="nl">Nefrogeen syndroom van inadequate antidiurese</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -339384,7 +339321,7 @@
     <Disorder id="14212">
       <OrphaCode>99429</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=99429</ExpertLink>
-      <Name lang="nl">Volledige androgeenongevoeligheidssyndroom</Name>
+      <Name lang="nl">Compleet androgeenongevoeligheidssyndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -339577,6 +339514,55 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="29566">
+      <OrphaCode>592574</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=592574</ExpertLink>
+      <Name lang="nl">Syndroom van Menke-Hennekam</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="16524">
+          <Source>PMID: 27311832; 29460469; 30892814</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Cases/families</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Case</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>27.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="16525">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="14245">
       <OrphaCode>99672</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=99672</ExpertLink>
@@ -342349,6 +342335,55 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="29432">
+      <OrphaCode>589527</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=589527</ExpertLink>
+      <Name lang="nl">Spinocerebellaire ataxie type 45</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="16540">
+          <Source>PMID: 29053796 ; 29847346</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Cases/families</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Case</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>7.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="16541">
+          <Source>PMID: 29053796 ; 29847346</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="29431">
       <OrphaCode>589522</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=589522</ExpertLink>
@@ -342370,8 +342405,8 @@
           </PrevalenceQualification>
           <PrevalenceClass/>
           <ValMoy>1.0</ValMoy>
-          <PrevalenceGeographic id="24936">
-            <Name lang="nl">Netherlands</Name>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
           </PrevalenceGeographic>
           <PrevalenceValidationStatus id="25958">
             <Name lang="nl">Validated</Name>
@@ -348262,7 +348297,7 @@
     <Disorder id="13989">
       <OrphaCode>98972</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=98972</ExpertLink>
-      <Name lang="nl">"Central cloudy" dystrofie van François</Name>
+      <Name lang="nl">Centrale troebele dystrofie van François</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -350513,6 +350548,76 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="29051">
+      <OrphaCode>583861</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=583861</ExpertLink>
+      <Name lang="nl">Geïsoleerde trombose van vena mesenterica</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="3">
+        <Prevalence id="16542">
+          <Source>PMID: 18720461; 25917534</Source>
+          <PrevalenceType id="23676">
+            <Name lang="nl">Jaarlijkse incidentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23746">
+            <Name lang="nl">1-9 / 100 000</Name>
+          </PrevalenceClass>
+          <ValMoy>1.6</ValMoy>
+          <PrevalenceGeographic id="23795">
+            <Name lang="nl">Europa</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="16543">
+          <Source>PMID: 25917534</Source>
+          <PrevalenceType id="23676">
+            <Name lang="nl">Jaarlijkse incidentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23739">
+            <Name lang="nl">1-9 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.5</ValMoy>
+          <PrevalenceGeographic id="24362">
+            <Name lang="nl">Finland</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="16544">
+          <Source>PMID: 18720461</Source>
+          <PrevalenceType id="23676">
+            <Name lang="nl">Jaarlijkse incidentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23746">
+            <Name lang="nl">1-9 / 100 000</Name>
+          </PrevalenceClass>
+          <ValMoy>2.7</ValMoy>
+          <PrevalenceGeographic id="25335">
+            <Name lang="nl">Sweden</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="13732">
       <OrphaCode>98715</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=98715</ExpertLink>
@@ -351828,7 +351933,24 @@
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="1">
+      <PrevalenceList count="2">
+        <Prevalence id="16434">
+          <Source>PMID: 29555651</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Cases/families</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Case</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>4.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
         <Prevalence id="16487">
           <Source>PMID: 29555651</Source>
           <PrevalenceType id="23669">
@@ -352215,7 +352337,7 @@
     <Disorder id="13392">
       <OrphaCode>98375</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=98375</ExpertLink>
-      <Name lang="nl">Auto-immune hemolytische anemie</Name>
+      <Name lang="nl">Auto-immuun hemolytische anemie</Name>
       <DisorderType id="21436">
         <Name lang="nl">Group of phenomes</Name>
       </DisorderType>
@@ -353222,7 +353344,7 @@
     <Disorder id="28673">
       <OrphaCode>570422</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=570422</ExpertLink>
-      <Name lang="nl">Galactosemutarotase-deficiëntie</Name>
+      <Name lang="nl">Deficiëntie van galactosemutarotase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -361705,7 +361827,7 @@
     <Disorder id="14462">
       <OrphaCode>99889</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=99889</ExpertLink>
-      <Name lang="nl">Cushingsyndroom door ectopische ACTH-secretie</Name>
+      <Name lang="nl">Syndroom van Cushing door ectopische ACTH-secretie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -362268,7 +362390,7 @@
     <Disorder id="14416">
       <OrphaCode>99843</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=99843</ExpertLink>
-      <Name lang="nl">Leukocytadhesiedeficiëntie type II</Name>
+      <Name lang="nl">Deficiëntie van leukocytenadhesie type II</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -362317,7 +362439,7 @@
     <Disorder id="14417">
       <OrphaCode>99844</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=99844</ExpertLink>
-      <Name lang="nl">Leukocytadhesiedeficiëntie type III</Name>
+      <Name lang="nl">Deficiëntie van leukocytenadhesie type III</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -363122,7 +363244,7 @@
     <Disorder id="14415">
       <OrphaCode>99842</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=99842</ExpertLink>
-      <Name lang="nl">Leukocytadhesiedeficiëntie type I</Name>
+      <Name lang="nl">Deficiëntie van leukocytenadhesie type I</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -363465,7 +363587,7 @@
     <Disorder id="14379">
       <OrphaCode>99806</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=99806</ExpertLink>
-      <Name lang="nl">Oculo-oto-dentaal syndroom</Name>
+      <Name lang="nl">Oculo-otodentaal syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
